Download PDF
Thromb Haemost 2005; 94(05): 1109-1110
DOI: 10.1055/s-0037-1616815
Letters to the Editor
Schattauer GmbH

Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels

Eduardo Rocha
1   University Clinic of Navarra, Pamplona, Spain
,
Antonio Gómez-Outes
2   Laboratorios Farmacéuticos Rovi, Madrid, Spain,
,
Javier Martínez Martínez
2   Laboratorios Farmacéuticos Rovi, Madrid, Spain,
,
Vijay Vir Kakkar
3   Thrombosis Research Institute, London, UK
› Author Affiliations
Further Information

Publication History

Received: 20 June 2005

Accepted after revision: 10 August 2005

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 1995; 98: 575-86.
    CrossrefPubMedGoogle Scholar
  • 2 Koren-Michowitz M, Avni B, Michowitz Y. et al. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiol Drug Saf 2004; 13: 299-302.
    CrossrefPubMedGoogle Scholar
  • 3 Gheno G, Cinetto L, Savarino C. et al. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin. Eur J Clin Pharmacol 2003; 59: 373-7.
    CrossrefPubMedGoogle Scholar
  • 4 Canova CR, Fischler MP, Reinhart WH. Effect of low molecular weight heparin on serum potassium. Lancet 1997; 349: 1447-8.
    PubMedGoogle Scholar
  • 5 Monreal M, Lafoz E, Salvador R. et al. Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalemia. Eur J Clin Pharmacol 1989; 37: 415-8.
    CrossrefPubMedGoogle Scholar
  • 6 Marcelli JM, Lalau JD, Abourachid H. et al. Unlike heparin, low-molecular weight heparin does not suppress aldosterone production. Horm Metab Res 1989; 21: 402.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Kakkar VV, Gebska M, Kadziola Z. et al. Low-molecular- weight heparin in the acute and long-term treatment of deep-vein trombosis. Thromb Haemost 2003; 89: 574-80.
    PubMedGoogle Scholar